Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

74.59
-1.2700-1.67%
Post-market: 74.590.00000.00%19:30 EDT
Volume:663.88K
Turnover:49.76M
Market Cap:6.61B
PE:-27.39
High:79.23
Open:76.84
Low:73.89
Close:75.86
52wk High:80.97
52wk Low:26.25
Shares:88.64M
Float Shares:64.73M
Volume Ratio:1.05
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:6.42
PE(LYR):-35.82

Loading ...

CG Oncology announces annual shareholder meeting

Reuters
·
Apr 25

Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Apr 21

CG Oncology Is Maintained at Overweight by JP Morgan

Dow Jones
·
Apr 18

JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’

TIPRANKS
·
Apr 17

CG Oncology Inc : JP Morgan Raises Target Price to $91 From $65

THOMSON REUTERS
·
Apr 17

U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon Mobil

Reuters
·
Apr 17

CG Oncology : Bofa Global Research Raises Price Objective to $84.00 From $72.00

THOMSON REUTERS
·
Apr 14

CG Oncology Inc - Appoints Jim Detore as CFO on April 13, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 13

CG Oncology appoints Jim DeTore as CFO

Reuters
·
Apr 13

BUZZ-U.S. STOCKS ON THE MOVE -Virgin Galactic, Humana, Broadcom

Reuters
·
Apr 07

CG Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 07

BUZZ-CG Oncology rises after brokerage lifts PT ahead of pivotal bladder cancer data

Reuters
·
Apr 07

CG Oncology price target raised to $100 from $80 at H.C. Wainwright

TIPRANKS
·
Apr 07

CG Oncology, Inc. : H.c. Wainwright Raises Target Price to $100 From $80

THOMSON REUTERS
·
Apr 07

CG Oncology, Inc. (CGON) Gets a Buy from JonesTrading

TIPRANKS
·
Apr 07

A Look At CG Oncology (CGON) Valuation As It Upsizes Its Planned US$550 Million Stock Offering

Simply Wall St.
·
Apr 06

LifeSci Capital Sticks to Its Buy Rating for CG Oncology, Inc. (CGON)

TIPRANKS
·
Mar 28

UBS Adjusts Price Target on CG Oncology to $90 From $60, Maintains Buy Rating

MT Newswires Live
·
Mar 26

Cretostimogene’s PIVOT‑6 Upside: Anticipated Superiority in Recurrence‑Free Survival Supports Buy on CG Oncology

TIPRANKS
·
Mar 25

Bank of America Securities Remains a Buy on CG Oncology, Inc. (CGON)

TIPRANKS
·
Mar 19